Diasource: Svar Life Science signs agreement to transfer RIA products & Neolisa CgA ELISA product to DIAsource ImmunoAssays
Svar Life Science signs strategic agreement to transfer the portfolio of radioimmunoassays RIA and the Chromogranin A Neolisa ELISA product to DIAsource ImmunoAssays a BioVendor group company.
Read full article »
DIAsource specializing in the development, sales and distribution of clinical diagnostics products.
Read more